More should be done to assess impact of ethnicity on breast cancer outcomes
This article was originally published in Scrip
Researchers are calling for mandatory ethnicity reporting in breast cancer treatment trials and sub-group analyses to identify intra-ethnic differences and determine how ethnicity influences treatment response and outcome. A patient's ethnicity could help determine the best treatment option, argue the researchers.
You may also be interested in...
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.
To maintain high prices and avoid access restrictions, companies marketing advanced therapies will have to show payers that their products save money elsewhere in the healthcare system.